Some Aspects of Molecular Diagnostics in Lynch Syndrome

Overview

Journal Hered Cancer Clin Pract

Publisher Biomed Central

Specialty Oncology

Date 2010 Mar 13

PMID 20223024

Citations 1

Authors

Grzegorz Kurzawski

Affiliations

Soon will be listed here.

Abstract

This manuscript is composed of five parts which summarize five publications in succession. Essentially, they are concerned with molecular diagnostics of Lynch syndrome and are based on studies in 238 families. The finding that young age at diagnosis is the key feature in patients with MSH2 and MLH1 mutations (Part 1) has helped to define simple criteria for the preliminary diagnosis of this syndrome. A cheaper method for the detection of mutations has been developed (Part 2) and applied to study the types of mutations and their prevalence in Poland (Part 3) and the Baltic States (Part 4). A specific feature of these mutations, i.e. presence of recurrent mutations in the majority of affected families with mutations, has suggested the feasibility of effective diagnostics with a single test disclosing all of them. An attempt to reveal other causes of familial aggregation of colorectal cancer has ruled out any association with C insertion in the NOD2 gene (Part 5).

Citing Articles

A Novel Mutation of Gene in a Patient with Lynch Syndrome Presenting with Thirteen Metachronous Malignancies.

Silinskaite U, Gaveliene E, Stulpinas R, Janavicius R, Poskus T J Clin Med. 2023; 12(17).

PMID: 37685569 PMC: 10488139. DOI: 10.3390/jcm12175502.

References

Vasen H, Watson P, Mecklin J, Lynch H . New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999; 116(6):1453-6. DOI: 10.1016/s0016-5085(99)70510-x. View

Lamberti C, Kruse R, Ruelfs C, Caspari R, Wang Y, Jungck M . Microsatellite instability-a useful diagnostic tool to select patients at high risk for hereditary non-polyposis colorectal cancer: a study in different groups of patients with colorectal cancer. Gut. 1999; 44(6):839-43. PMC: 1727554. DOI: 10.1136/gut.44.6.839. View

Park J, Vasen H, Park K, Peltomaki P, Ponz de Leon M, Rodriguez-Bigas M . Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis. Dis Colon Rectum. 1999; 42(6):710-5; discussion 715-6. DOI: 10.1007/BF02236922. View

Wang Q, Lasset C, Desseigne F, Saurin J, Maugard C, Navarro C . Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer. Hum Genet. 1999; 105(1-2):79-85. DOI: 10.1007/s004399900064. View

Liu T, Wahlberg S, Burek E, Lindblom P, Rubio C, Lindblom A . Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial colorectal cancer. Genes Chromosomes Cancer. 1999; 27(1):17-25. DOI: 10.1002/(sici)1098-2264(200001)27:1<17::aid-gcc3>3.0.co;2-y. View

Debniak T, Kurzawski G, Gorski B, Kladny J, Domagala W, Lubinski J . Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer. Eur J Cancer. 2000; 36(1):49-54. DOI: 10.1016/s0959-8049(99)00208-7. View

Syngal S, Fox E, Eng C, Kolodner R, Garber J . Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet. 2000; 37(9):641-5. PMC: 1734690. DOI: 10.1136/jmg.37.9.641. View

Ogura Y, Inohara N, Benito A, Chen F, Yamaoka S, Nunez G . Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem. 2000; 276(7):4812-8. DOI: 10.1074/jbc.M008072200. View

Jakubowska A, Gorski B, Kurzawski G, Debniak T, Hadaczek P, Cybulski C . Optimization of experimental conditions for RNA-based sequencing of MLH1 and MSH2 genes. Hum Mutat. 2001; 17(1):52-60. DOI: 10.1002/1098-1004(2001)17:1<52::AID-HUMU6>3.0.CO;2-E. View

10.

Wu Y, Berends M, Post J, Mensink R, Verlind E, van der Sluis T . Germline mutations of EXO1 gene in patients with hereditary nonpolyposis colorectal cancer (HNPCC) and atypical HNPCC forms. Gastroenterology. 2001; 120(7):1580-7. DOI: 10.1053/gast.2001.25117. View

11.

Ogura Y, Bonen D, Inohara N, Nicolae D, Chen F, Ramos R . A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001; 411(6837):603-6. DOI: 10.1038/35079114. View

12.

Xiao W, Oefner P . Denaturing high-performance liquid chromatography: A review. Hum Mutat. 2001; 17(6):439-74. DOI: 10.1002/humu.1130. View

13.

Liu T, Yan H, Kuismanen S, Percesepe A, Bisgaard M, Pedroni M . The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res. 2001; 61(21):7798-802. View

14.

Al-Tassan N, Chmiel N, Maynard J, Fleming N, Livingston A, Williams G . Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors. Nat Genet. 2002; 30(2):227-32. DOI: 10.1038/ng828. View

15.

Kurzawski G, Safranow K, Suchy J, Chlubek D, Scott R, Lubinski J . Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography. J Biochem Biophys Methods. 2002; 51(1):89-100. DOI: 10.1016/s0165-022x(02)00003-9. View

16.

Cuthbert A, Fisher S, Mirza M, King K, Hampe J, Croucher P . The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology. 2002; 122(4):867-74. DOI: 10.1053/gast.2002.32415. View

17.

Park J, Vasen H, Park Y, Park K, Peltomaki P, de Leon M . Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study. Int J Colorectal Dis. 2002; 17(2):109-14. DOI: 10.1007/s003840100348. View

18.

Kurzawski G, Suchy J, Kladny J, Safranow K, Jakubowska A, Elsakov P . Germline MSH2 and MLH1 mutational spectrum in HNPCC families from Poland and the Baltic States. J Med Genet. 2002; 39(10):E65. PMC: 1734972. DOI: 10.1136/jmg.39.10.e65. View

19.

Gille J, Hogervorst F, Pals G, Wijnen J, van Schooten R, Dommering C . Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer. 2002; 87(8):892-7. PMC: 2376172. DOI: 10.1038/sj.bjc.6600565. View

20.

Foulkes W, Thiffault I, Gruber S, Horwitz M, Hamel N, Lee C . The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet. 2002; 71(6):1395-412. PMC: 420003. DOI: 10.1086/345075. View